These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 33845844)
1. LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation BCL2L11. Pan Q; Huang Y; Wang Y; Li D; Lei C Cancer Cell Int; 2021 Apr; 21(1):203. PubMed ID: 33845844 [TBL] [Abstract][Full Text] [Related]
2. Mechanism underlying the regulation of lncRNA ACTA2-AS1 on CXCL2 by absorbing miRNA-532-5p as ceRNA in the development of ovarian cancer. Li Y; Yang Z; Chen J Int J Clin Exp Pathol; 2021; 14(5):596-607. PubMed ID: 34093945 [TBL] [Abstract][Full Text] [Related]
3. A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression. Luo L; Wang M; Li X; Luo C; Tan S; Yin S; Liu L; Zhu X Cancer Cell Int; 2020; 20():372. PubMed ID: 32774166 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis. Liu J; Qian J; Mo Q; Tang L; Xu Q Bioengineered; 2022 Mar; 13(3):5407-5420. PubMed ID: 35176937 [TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα. Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111 [TBL] [Abstract][Full Text] [Related]
6. LncRNA HAND2-AS1 inhibits 5-fluorouracil resistance by modulating miR-20a/PDCD4 axis in colorectal cancer. Jiang Z; Li L; Hou Z; Liu W; Wang H; Zhou T; Li Y; Chen S Cell Signal; 2020 Feb; 66():109483. PubMed ID: 31760170 [TBL] [Abstract][Full Text] [Related]
7. E2F1-mediated MNX1-AS1-miR-218-5p-SEC61A1 feedback loop contributes to the progression of colon adenocarcinoma. Ye Y; Gu B; Wang Y; Shen S; Huang W J Cell Biochem; 2019 Apr; 120(4):6145-6153. PubMed ID: 30362161 [TBL] [Abstract][Full Text] [Related]
8. LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137. Lu Y; Guo G; Hong R; Chen X; Sun Y; Liu F; Zhang Z; Jin X; Dong J; Yu K; Yang X; Nan Y; Huang Q Front Oncol; 2021; 11():634893. PubMed ID: 34094916 [TBL] [Abstract][Full Text] [Related]
9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a. Xu L; Hou TJ; Yang P Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890 [TBL] [Abstract][Full Text] [Related]
11. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression. Yang X; Xing G; Liu S; Li B; He Y; Wang F Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA OIP5-AS1 promotes pancreatic cancer cell growth through sponging miR-342-3p via AKT/ERK signaling pathway. Meng X; Ma J; Wang B; Wu X; Liu Z J Physiol Biochem; 2020 May; 76(2):301-315. PubMed ID: 32157498 [TBL] [Abstract][Full Text] [Related]
13. LncRNA FOXC2-AS1 regulated proliferation and apoptosis of vascular smooth muscle cell through targeting miR-1253/FOXF1 axis in atherosclerosis. Wang YQ; Xu ZM; Wang XL; Zheng JK; Du Q; Yang JX; Zhang HC Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3302-3314. PubMed ID: 32271448 [TBL] [Abstract][Full Text] [Related]
14. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p. Peng X; Yan J; Cheng F Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259 [TBL] [Abstract][Full Text] [Related]
15. Down-regulated lncRNA SBF2-AS1 inhibits tumorigenesis and progression of breast cancer by sponging microRNA-143 and repressing RRS1. Xia W; Liu Y; Cheng T; Xu T; Dong M; Hu X J Exp Clin Cancer Res; 2020 Jan; 39(1):18. PubMed ID: 31952549 [TBL] [Abstract][Full Text] [Related]
16. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Bai T; Liu Y; Li B IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543 [TBL] [Abstract][Full Text] [Related]
17. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis. Qiu Z; Pan XX; You DY Neoplasma; 2020 Jul; 67(4):871-879. PubMed ID: 32386483 [TBL] [Abstract][Full Text] [Related]
18. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA MAFG-AS1 knockdown blocks malignant progression in breast cancer cells by inactivating JAK2/STAT3 signaling pathway via MAFG-AS1/miR-3196/TFAP2A axis. Ding M; Fu Y; Guo F; Chen H; Fu X; Tan W; Zhang H Int J Clin Exp Pathol; 2020; 13(10):2455-2473. PubMed ID: 33165437 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]